Companies

AllovirĀ Inc

NASDAQ: ALVR
$4.10
ā–² $0.02 (+0.49%) today
Markets closed Ā· 2:13am ET
Today Ā· % change

About ALVR

Allovir, Inc., a clinical-stage cell therapy company, is dedicated to the research and development of ready-to-use, multi-virus-specific allogeneic T-cell therapies (TSVs) to prevent and treat devastating virus-associated diseases. The company is headquartered in Cambridge, Massachusetts.

ALVR Coverage

9:54am ET
Telecom & Wireless

Stocks Under $10: Alvarion (ALVR)

Alvarion (ALVR) This company is a leader in building WiMax infrastructure. The shares trade at $9.60, down from a 52-week high of $15.21. An analyst writing in The New York Post thinks…

Douglas A. McIntyre
6:46am ET
Investing

Pre-Market Analyst Calls (October 1, 2007)

AMR cut to Hold at Citigroup.ALVR raised to positive at Susquehanna.CHTR started as Overweight at JPMorgan.CME raised to Outperform at Wachovia.COMS cut to Neutral at UBS.COP cut to Sell at Deutsche Bank.CTXS…

Douglas A. McIntyre
7:11am ET
Investing

Pre-Market Stock News (September 17, 2007)

(ALVR) Alvarion won a WiMAX contract from Digicel Group in the Cayman Islands.(CTSH) Cognizant Tech announced a 2 for 1 stock split and authorized up to $100 million for share buybacks.(CX) CEMEX…

Douglas A. McIntyre
6:28am ET
Investing

Pre-Market Analyst Calls (July 20, 2007)

ADSK cut to Hold at Citigroup.ALEX cut to Mkt Perform at Wachovia.ALVR cut to Sector Perform at CIBC.BMI cut to Neutral at Baird.CLWR cut to Hold at Jefferies.CYBS cut to Mkt Perform…

Douglas A. McIntyre
7:17am ET
Investing

Pre-Market Stock News (June 28, 2007)

(AAPL) Apple’s iPhone launches tomorrow.(ABPI) Accentia Biopharma announced favorable interim blinded data on SinuNase in its fast-tracked pivotal Phase III clinical trial.(ALVR) Alvarion in pact with Australian government over a WiMAX contract…

Douglas A. McIntyre